HHealthcare Read More Novo Nordisk Launches Affordable Ozempic Copy in South Africa, ETPharmaJuly 20, 2026 Johannesburg: Novo Nordisk will launch a more affordable authorised copy of its Ozempic diabetes drug in South Africa…
HHealthcare Read More Could This Healthcare Stock Help You Build a Real Fortune Over the Next 20 Years?July 6, 2026 The short, but glib, answer to the headline question posed for Viking Therapeutics (NASDAQ: VKTX) investors is “no,”…
HHealth Read More UK pharmacies braced for surge in demand as Wegovy pill now availableJuly 5, 2026 Pharmacies in the UK are “bracing themselves” for a surge in patients starting weight loss drugs as the…
MMedication Read More Canada approves generic version of Wegovy for weight lossJuly 3, 2026 FILE – A dosage of Wegovy, March 1, 2024 in Front Royal, Va. (AP Photo/Amanda Andrade-Rhoades, File) –…
HHealthcare Read More Novo Nordisk A/S (NVO) Primary Owner to Open Obesity Drug Incubators Across EuropeJune 28, 2026 Novo Nordisk A/S (NYSE:NVO) is among the Best Pharmaceutical Stocks. On June 19, Novo Nordisk A/S (NYSE:NVO)’s primary owner,…
HHealthcare Read More The Artificial Intelligence Opportunity Beyond Big Tech: 3 Healthcare Stocks to WatchJune 27, 2026 Investors looking to capitalize on the rapidly growing artificial intelligence (AI) industry tend to turn toward leading tech…
HHealthcare Read More UPS invests $48 million in cold-chain healthcare logisticsJune 25, 2026 A $48 million buildout of 27 temperature-controlled facilities spanning the Americas, Europe, and Asia is underway at UPS,…
MMedication Read More Oral Wegovy Captures One-Third of Prescriptions as Adoption Continues to AccelerateJune 18, 2026 tablets pills medicine bottle NEW SIZE ©PXHere Novo Nordisk (NYSE:NVO) is seeing strong uptake of its oral Wegovy…
MMedication Read More The Latest Ozempic Side Effect? It May Make You Less ViolentJune 18, 2026 Topline GLP-1 medications like Ozempic and Wegovy may reduce the risk of violent criminal behavior among current users,…
HHealthcare Read More Novo Nordisk comeback stirs as Wegovy pill wins UK approvalJune 13, 2026 The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Novo Nordisk’s Wegovy (semaglutide) pill, marking another…
MMedication Read More Generic semaglutide market shows signs of excess inventory bulge | Industry NewsJune 13, 2026 Pharmarack data indicates elevated stock levels across several recently launched brands amid slower-than-expected liquidation in the trade…
HHealthcare Read More Novo Nordisk shares retreat after ADA conference updates fail to excite investors (NVO)June 8, 2026 chart down red arrow NEW SIZE ©Shutterstock Novo Nordisk (NYSE:NVO) shares fell 3% on Monday as investors digested…